Virtual Reality for Postoperative Pain Management

Oregon Health & Science University (OHSU)

Status: Completed

Conditions: Surgery; Incision; Pain, Postoperative; Otolaryngological Disease

Treatments: Device: Smartphone; Device: Virtual Reality (Oculus Quest)

Study type: Interventional

Funder types: Other

Identifiers

NCT04464304

00020777

Details and patient eligibility

About

This trial studies an active virtual reality (VR) experience as a means for non-pharmacologic postoperative pain management among patients after head and neck surgery. Investigators will assess differences in pain scores, analgesic use, and subjective patient experiences between patients participating in a VR activity and patients participating in the same activity using a smartphone.

Full description

Management of postoperative pain after head and neck surgery is complex, and has received increased attention to improve patient recovery and quality of life. Narcotic analgesics are frequently utilized in postoperative pain management, but these have risks including nausea, sedation, constipation, and dependence. Multimodal analgesia can reduce narcotic use and improve recovery, but medical comorbidities may contraindicate the use of certain medications. Non-pharmacologic measures for postoperative pain control may provide novel and cost-effective strategies to confront this complex issue.

Patients undergoing head and neck surgery will be randomly allocated to participate in an immersive experience in VR, or to participate in a similar experience on a two-dimensional screen using a smartphone.

Enrollment: 30 patients

Sex: All

Ages: 18 to 89 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients who have undergone head and neck surgery with an average pain score of 3 or greater out of 10 during the 24 hours preceding the screening
• Are able to provide informed consent
• Are not in the intensive care unit (ICU)

Exclusion criteria

• Symptoms concerning for an active respiratory infection including fever, cough, and shortness of breath or confirmed respiratory infection
• Active eye discharge
• Active nausea or vomiting
• History of seizure, epilepsy, or hypersensitivity to flashing light
• History of motion sickness or vertigo
• Have wound dressings on the head or neck that prevent comfortable and safe use of the virtual reality headset

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

30 participants in 2 patient groups

Virtual Reality

Active Comparator group

Description:

Patients will be provided with a commercially-available VR device for use up to 15 minutes at bedside.

Treatment:

Device: Virtual Reality (Oculus Quest)

Smartphone

Sham Comparator group

Description:

Patients will be provided with a commercially-available smartphone device for use up to 15 minutes at bedside.

Treatment:

Device: Smartphone